Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,575 USD | -0,94 % | -1,29 % | +11,66 % |
15/03 | ATYR PHARMA, INC. : RBC Capital Markets mantiene su recomendación de compra | ZM |
14/03 | Transcript : ATyr Pharma, Inc., Q4 2023 Earnings Call, Mar 14, 2024 |
Resumen de negocios
Número de empleados: 58
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 10 | 100,0 % | 0 | 100,0 % | -96,60 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 30/07/18 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/15 |
Ashlee Dunston
IRC | Investor Relations Contact | - | 01/04/20 |
Peter Villiger
PRN | Corporate Officer/Principal | - | 01/05/16 |
Human Resources Officer | - | 24/12/21 | |
General Counsel | - | 06/10/21 | |
Leslie Nangle
PRN | Corporate Officer/Principal | - | - |
Nancy Krueger
LAW | General Counsel | 56 | 01/10/14 |
Andrew B. Cubitt
PRN | Corporate Officer/Principal | - | 01/09/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 08/09/05 |
Tim Coughlin
CHM | Chairman | 57 | 10/04/17 |
John Clarke
BRD | Director/Board Member | 70 | 01/09/05 |
Sara Zaknoen
BRD | Director/Board Member | 65 | 25/05/21 |
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 30/03/16 |
Jane Gross
BRD | Director/Board Member | 67 | 28/06/19 |
Svetlana Lucas
BRD | Director/Board Member | 52 | 28/06/19 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 67 940 841 | 66 158 839 ( 97,38 %) | 0 | 97,38 % |
Información de la empresa
aTyr Pharma, Inc.
10240 Sorrento Valley Road Suite 300
92121, San Diego
+858 731 8389
http://www.atyrpharma.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+11,66 % | 108 M | |
+21,41 % | 42,68 mil M | |
-2,55 % | 42,4 mil M | |
+45,32 % | 40,04 mil M | |
-6,20 % | 28,31 mil M | |
+8,01 % | 24,94 mil M | |
-20,10 % | 18,96 mil M | |
+30,08 % | 12,3 mil M | |
-2,48 % | 11,95 mil M | |
-2,76 % | 11,55 mil M |
- Bolsa de valores
- Acciones
- Acción LIFE
- Empresa aTyr Pharma, Inc.